1. Anti-human hepatoma Hep-G2 proliferative, apoptotic, and antimutagenic activity of tagitinin C from Tithonia diversifolia leaves.
- Author
-
Liao MH, Tsai YN, Yang CY, Juang CL, Lee MY, Chang LH, and Wen HC
- Subjects
- Animals, Antimutagenic Agents chemistry, Female, Hep G2 Cells, Humans, Mice, Mice, Inbred BALB C, Mice, Nude, Plant Extracts chemistry, Plant Extracts pharmacology, Plant Extracts therapeutic use, Sesquiterpenes chemistry, Xenograft Model Antitumor Assays, Antimutagenic Agents pharmacology, Antimutagenic Agents therapeutic use, Apoptosis drug effects, Asteraceae chemistry, Plant Leaves chemistry, Sesquiterpenes pharmacology, Sesquiterpenes therapeutic use
- Abstract
Tagitinin C, a major sesquiterpenoid, was isolated from the leaves of Tithonia diversifolia. The high morbidity and mortality rate of hepatoma in Taiwan motivated our interest in the investigation of tagitinin C's mechanism against the human hepatocellular carcinoma. The methanolic extract of leaves of T. diversifolia (TDM) and tagitinin C were found to have cytotoxic activities against human hepatoma Hep-G2 cells in the MTT assay with IC(50) values of 40.0 ± 2.0 and 2.0 ± 0.1 μg/mL, respectively. This compound induced population increase in the sub-G(1) phase and S phase arrest. Treatment with tagitinin C isolated from TDM resulted in activation of both caspase 3 and caspase 8 which suggested that the antiproliferative effect of this compound was caspase-dependent apoptosis. Magnetic resonance techniques indicated that the tumorigenisity of xenografts derived from Hep-G2 cells was retarded by the delivery of tagitinin C (15 μg/mouse/day) relative to the control counterparts.
- Published
- 2013
- Full Text
- View/download PDF